Digital Therapeutics Market Latest In-Depth Report and Forecast 2021 to 2027

Precedence Research, Recently Announced Report on “Digital Therapeutics Market Size, Share, Trends, Growth, Revenue, Company Analysis, Regional Insights and Forecast 2021-2027”.

The Digital Therapeutics market research report provides a succinct analysis on the recent market trends. In addition, the report offers a thorough abstract on the statistics, market estimates and revenue forecasts, which further highlights its position in the industry, in tandem with the growth strategies adopted by leading industry players.

The study on Digital Therapeutics market presents a comprehensive analysis of the key growth markers of this industry vertical in accordance with the regional outlook and competitive landscape. Also, the report discusses the prevalent challenges and limitations in this business sphere. Moreover, it renders a robust outlook on the opportunities that can turn in profit over the projected timeline. In addition, a conclusive overview of the impact of Covid-19 pandemic is included to empower stakeholders with the latest updates on changing market.

Request Coronavirus Impact Analysis on This [email protected] https://www.precedenceresearch.com/sample/1128

Key highlights from COVID-19 impact analysis:

  • Contractions in economic growth due to the spread of COVID-19.
  • Shifts in the supply and demand facets.
  • Immediate and long-term impact of COVID-19 on business growth.

Key Players

  • Fitbit Health Solutions
  • 2MORROW, Inc.
  • Medtronic Plc.
  • Livongo Health, Inc.
  • Pear Therapeutics, Inc.
  • Omada Health, Inc.
  • Resmed, Inc. (Propeller Health)
  • Proteus Digital Health, Inc.
  • Welldoc, Inc.
  • Voluntis, Inc.
  • Canary Health Inc.
  • Noom, Inc.
  • Mango Health Inc.
  • Dthera Sciences

Other Highlights:

  • Thorough assessment of the listed companies, including their manufactured goods as well as market remuneration and production patterns is offered in the report.
  • The study also provides information regarding the market share held by the companies, along with their gross margin and price patterns.
  • Pivotal details regarding the revenue and volume estimates of every product type are showcased.
  • Other important aspects like market share; growth rate and production trends of each product over the analysis period are elaborated.
  • The research evaluates the market share of each application and predicts their growth rate during the study period.
  • Industry share of each application and their growth rate forecasts are also expounded.
  • Major competition trends, as well as insights on the industry supply chain are highlighted.
  • Further, the report endorses Porter’s five forces analysis and SWOT analysis to realize the feasibility of a new project.

Segmentation

By Product

  • Device
  • Software

By Sales Channel

  • Business-to-Consumer (B2C)
    • Caregiver
    • Patient
  • Business-to-Business (B2B)
    • Healthcare Provider
    • Employer
    • Others

By Application

  • Obesity
  • Diabetes
  • Central Nervous System (CNS) Disease
  • Gastrointestinal Disorder (GID)
  • Cardiovascular Disease (CVD)
  • Smoking Cessation
  • Respiratory Disease
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

An overview of the regional landscape:

  • Geographically, the Digital Therapeutics market is segmented into North America, Europe, Asia-Pacific, Southeast Asia, Middle East and Africa, South America.
  • Performance of the regional markets alongside their respective growth rate over the forecast timeframe is mentioned in the report.
  • Brief comprehension of the revenue generated and sales garnered by region is included.

Comprehensive assessment of all opportunities and risks in the Digital Therapeutics market.

  • The Digital Therapeutics market recent innovations and major events.
  • A detailed study of business strategies for the growth of the Digital Therapeutics market-leading players.
  • Conclusive study about the growth plot of the Digital Therapeutics market for forthcoming years.
  • In-depth understanding of Digital Therapeutics market-particular drivers, constraints, and major micro markets.
  • Favorable impression inside vital technological and market latest trends striking the Digital Therapeutics market.

This exclusive study addresses key questions for stakeholders in the Digital Therapeutics market:

  • What are the key developments anticipated to take place in the Digital Therapeutics market during the period of 2020-2027?
  • What are the crucial strategies adopted by players operating in the Digital Therapeutics market?
  • Which end-user segment will remain a key contributor to the growth of the Digital Therapeutics market?
  • What are the important trends stimulating the growth of the Digital Therapeutics market?

Which application segment will bode lucrative growth opportunities for the Digital Therapeutics market?

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Digital Therapeutics Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Market SWOT Analysis

Chapter 5. COVID 19 Impact on Digital Therapeutics Market

5.1. Covid-19: Digital Therapeutics Industry Impact
5.2. Digital Therapeutics Business Impact Assessment: Covid-19
5.2.1. Distribution Channel Challenges/Disruption
5.2.2. Market Trends and Digital Therapeutics Opportunities in the COVID-19 Landscape
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Digital Therapeutics Manufacturers to deal with Covid-19 Pandemic Scenario

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing Penetration of Digital Healthcare Applications & Platforms
6.1.1.2. Rapid Adoption of Smartphones & Tablets
6.1.2. Market Restraints
6.1.2.1. Lack of Proper Monetization Strategy
6.1.3. Market Opportunities
6.1.3.1. Implementation of Machine Learning and Artificial Intelligence in Digital Therapeutics Platforms

Chapter 7. Global Digital Therapeutics Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Digital Therapeutics Market Revenue by Manufacturer (2015-2020)
7.1.1.2. Digital Therapeutics Market Revenue Market Share by Manufacturer (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global Digital Therapeutics Market, By Product Type

8.1. Digital Therapeutics Market, by Product Type, 2016-2027
8.1.1. Device
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Digital Therapeutics Market, By Sales Channel

9.1. Digital Therapeutics Market, by Sales Channel, 2016-2027
9.1.1. Business-to-Consumer (B2C)
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.1.2. Caregiver
9.1.1.3. Patient
9.1.2. Business-to-Business (B2B)
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.2.2. Healthcare Provider
9.1.2.3. Employer
9.1.2.4. Others

Chapter 10. Global Digital Therapeutics Market, By Application

10.1. Digital Therapeutics Market, by Application, 2016-2027
10.1.1. Obesity
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Diabetes
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Central Nervous System (CNS) Disease
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Gastrointestinal Disorder (GID)
10.1.4.1. Market Revenue and Forecast (2016-2027)
10.1.5. Cardiovascular Disease (CVD)
10.1.5.1. Market Revenue and Forecast (2016-2027)
10.1.6. Smoking Cessation
10.1.6.1. Market Revenue and Forecast (2016-2027)
10.1.7. Respiratory Disease
10.1.7.1. Market Revenue and Forecast (2016-2027)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2016-2027)

Chapter 11. Global Digital Therapeutics Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product Type (2016-2027)
11.1.2. Market Revenue Forecast by Sales Channel (2016-2027)
11.1.3. Market Revenue Forecast by Application (2016-2027)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2016-2027)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2016-2027)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type (2016-2027)
11.2.2. Market Revenue Forecast by Sales Channel (2016-2027)
11.2.3. Market Revenue Forecast by Application (2016-2027)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2016-2027)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2016-2027)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2016-2027)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2016-2027)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type (2016-2027)
11.3.2. Market Revenue Forecast by Sales Channel (2016-2027)
11.3.3. Market Revenue Forecast by Application (2016-2027)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2016-2027)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2016-2027)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2016-2027)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type (2016-2027)
11.4.2. Market Revenue Forecast by Sales Channel (2016-2027)
11.4.3. Market Revenue Forecast by Application (2016-2027)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2016-2027)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2016-2027)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type (2016-2027)
11.5.2. Market Revenue Forecast by Sales Channel (2016-2027)
11.5.3. Market Revenue Forecast by Application (2016-2027)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2016-2027)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2016-2027)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2016-2027)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2016-2027)

Chapter 12. Company Profiles

12.1. Fitbit Health Solutions
12.1.1. Company Overview, Business Information, Manufacturing Area
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. 2MORROW, Inc.
12.2.1. Company Overview, Business Information, Manufacturing Area
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Medtronic Plc.
12.3.1. Company Overview, Business Information, Manufacturing Area
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. Livongo Health, Inc.
12.4.1. Company Overview, Business Information, Manufacturing Area
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. Pear Therapeutics, Inc.
12.5.1. Company Overview, Business Information, Manufacturing Area
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Omada Health, Inc.
12.6.1. Company Overview, Business Information, Manufacturing Area
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. Resmed, Inc. (Propeller Health)
12.7.1. Company Overview, Business Information, Manufacturing Area
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Proteus Digital Health, Inc.
12.8.1. Company Overview, Business Information, Manufacturing Area
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. Welldoc, Inc.
12.9.1. Company Overview, Business Information, Manufacturing Area
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. Voluntis, Inc.
12.10.1. Company Overview, Business Information, Manufacturing Area
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0Shares